Boulder, CO, United States of America

Darren Barry Smith



 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2018-2022

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Darren Barry Smith

Introduction

Darren Barry Smith is a notable inventor based in Boulder, CO (US). He has made significant contributions to the field of microfluidics, particularly in the testing of LAL-reactive substances. With a total of 3 patents to his name, Smith's work exemplifies the intersection of technology and healthcare.

Latest Patents

One of Smith's latest patents is the "Centripetal microfluidic platform for LAL reactive substances testing." This innovative platform consists of a microfluidics disc and a reader designed for testing LAL-reactive substances in fluid samples. The microfluidic disc features at least two testing areas, each containing a reservoir for fluid samples. The distribution network within the disc includes at least four channels, each equipped with a metering portion and an analysis chamber. The analysis chamber is designed for mixing samples and reagents, and it includes an optical chamber compatible with an optical reader. This technology allows for precise testing of fluid samples, enhancing the reliability of results in medical applications.

Career Highlights

Throughout his career, Darren Barry Smith has worked with prominent companies such as Bl Technologies, Inc. and General Electric Company. His experience in these organizations has contributed to his expertise in developing innovative solutions in the field of microfluidics.

Collaborations

Smith has collaborated with notable professionals in his field, including Paul Charles Melanson and Richard D Godec. These collaborations have further enriched his work and expanded the impact of his inventions.

Conclusion

Darren Barry Smith's contributions to microfluidics and his innovative patents demonstrate his commitment to advancing technology in healthcare. His work continues to influence the field and improve testing methods for LAL-reactive substances.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…